Rheumatology (Oxford, England) · 2026
Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iacovantuono Maria, Landini Nicholas, Jungblut Lisa, Sauer Gesa M, Käs Florian, Dobrota Rucsandra, Muraru Sinziana, Elhai Muriel, Mihai Carina, Becker Mike O, Chimenti Maria Sole, Frauenfelder Thomas, Hoffmann-Vold Anna-Maria, Distler Oliver, Bruni Cosimo
Аннотация
OBJECTIVE: The automated assessment of chest high-resolution CT (HRCT) scans allows the objective quantification of interstitial lung disease (ILD)-related features. Here, we explored the ability of HRCT-derived radiomic features to predict all-cause mortality and ILD progression in SSc-ILD patients.
METHODS: We analysed baseline and follow-up HRCT scans of SSc-ILD patients using lung texture analysis (LTA™, Imbio). Lung parenchymal alterations (honeycombing, ground-glass, reticulation, hyperlucency) and pulmonary vessel volume (PVV) were quantified as percentages of the respective lung volume-for whole lungs and for upper, middle and lower zones. Univariable and multivariable Cox regression and generalized estimating equation (GEE) models were applied to identify radiomics predictors of all-cause mortality and ILD progression, respectively.
RESULTS: Of 313 SSc-ILD patients, 267 (85%) were eligible for radiomic analysis and were included in the mortality analysis; 160 (60%) were included in the progression analysis. Over 42 [interquartile range (IQ)R 27-110] months of follow-up, 65 (24%) patients died. They presented with a greater extent of PVV% and parenchymal alterations across all lung zones, compared with patients who survived. PVV% independently predicted mortality [adjusted hazard ratio (HR) 1.21, 95% CI 1.094-1.354], particularly in the upper zones (adjusted HR 1.28, 95% CI 1.11-1.46). Among 261 yearly follow-up visits from 160 SSc-ILD patients, 50.6% showed at least one episode of ILD progression, for a total of 99 (37.7%) episodes. Baseline radiomic features were overall comparable between progressors and non-progressors. The extent of whole-lung honeycombing was identified as the only independent radiomic predictor of ILD progression [adjusted odds ratio 1.53, 95% CI 1.17-2.01].
CONCLUSION: The PVV% and the extent of honeycombing independently predict mortality and ILD progression, respectively. These radiomic features might support risk stratification of SSc-ILD patients, on top of functional and clinical characteristics.
METHODS: We analysed baseline and follow-up HRCT scans of SSc-ILD patients using lung texture analysis (LTA™, Imbio). Lung parenchymal alterations (honeycombing, ground-glass, reticulation, hyperlucency) and pulmonary vessel volume (PVV) were quantified as percentages of the respective lung volume-for whole lungs and for upper, middle and lower zones. Univariable and multivariable Cox regression and generalized estimating equation (GEE) models were applied to identify radiomics predictors of all-cause mortality and ILD progression, respectively.
RESULTS: Of 313 SSc-ILD patients, 267 (85%) were eligible for radiomic analysis and were included in the mortality analysis; 160 (60%) were included in the progression analysis. Over 42 [interquartile range (IQ)R 27-110] months of follow-up, 65 (24%) patients died. They presented with a greater extent of PVV% and parenchymal alterations across all lung zones, compared with patients who survived. PVV% independently predicted mortality [adjusted hazard ratio (HR) 1.21, 95% CI 1.094-1.354], particularly in the upper zones (adjusted HR 1.28, 95% CI 1.11-1.46). Among 261 yearly follow-up visits from 160 SSc-ILD patients, 50.6% showed at least one episode of ILD progression, for a total of 99 (37.7%) episodes. Baseline radiomic features were overall comparable between progressors and non-progressors. The extent of whole-lung honeycombing was identified as the only independent radiomic predictor of ILD progression [adjusted odds ratio 1.53, 95% CI 1.17-2.01].
CONCLUSION: The PVV% and the extent of honeycombing independently predict mortality and ILD progression, respectively. These radiomic features might support risk stratification of SSc-ILD patients, on top of functional and clinical characteristics.